Skip to content
healthcare.dev

TEVIMBRA

NDC 72579-121, tislelizumab-jsgr, injection, solution, concentrate, from BeOne Medicines USA, Inc..

Product NDC
72579-121
Status
Listed
Labeler
BeOne Medicines USA, Inc.
Dosage form
INJECTION, SOLUTION, CONCENTRATE
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761232
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72579-121 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TISLELIZUMAB10 mg/mL

Pharmacologic classes

Programmed Death Receptor-1 Blocking Antibody [EPC]; Programmed Death Receptor-1-directed Antibody Interactions [MoA]

Package NDCNDC-11Package
72579-121-01725790121011 VIAL, GLASS in 1 CARTON (72579-121-01) / 10 mL in 1 VIAL, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/08ef1e3e-496f-4b0b-94ee-fbba3cc1985a
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=72579-121

Use it

Look up 72579-121 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72579-121 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72579-121. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.